Objective Endoscopic sinus surgery (ESS) and endoscopic skull base surgery (ESBS)
approaches have revolutionized the management of sinonasal and intracranial pathology …

Background Postoperative surgical site hematoma (SSH) following lumbosacral surgery
carries significant morbidity and increased length of stay (LOS). Intravenous tranexamic acid …

Background The interactions of polytrauma, shock, and traumatic brain injury (TBI) on
thromboinflammatory responses remain unclear and warrant investigation as we strive …

Objective To conduct a bibliometric analysis of literature on hemorrhagic shock published
between 2000 and 2021 with the help of Citespace to explore the current status, hotspots …

Purpose The effect of systemic hemostatic agents initiated during pre-hospital care of
severely injured patients with ongoing bleeding or traumatic brain injury (TBI) remains …

INTRODUCTION Tranexamic acid (TXA) or trans-4-amino-methyl-cyclohexane-carbonic
acid is a synthetic analog derivative of amino acid lysine that inhibits fibrinolysis by …

Introduction Severe hemorrhage is the leading cause of early preventable death in severe
trauma patients. Delayed diagnosis is a poor prognostic factor, and severe hemorrhage …

Tranexamic acid (TXA), a synthetic antifibrinolytic drug, has proven efficacy and is
recommended for major pediatric surgery to decrease perioperative blood loss …

Background and objectives Tranexamic acid (TXA) is poorly studied in patients with bone
and musculoskeletal sarcoma due to perceived increased risk of venous thromboembolism …

OBJECTIVES: Tranexamic acid (TXA) administration confers a survival benefit in bleeding
trauma patients; however, data regarding its use in pediatric patients are limited. This study …